Within the 5-year survivor cohort, there was significant (P < 0.05) enrichment of cellular interaction between PDPN+ CD21+ B cells, CD21+ B cells, Proliferating cells, as well as Lymphatic Endothelial cells with Tumor cells (Fig. 4e). The gene discussed is PDPN; the disease is neoplasm.